Patents versus Patients

Five years after the Doha Declaration

Briefing Paper

Published: Nov 14, 2006

Publication Summary

Five years ago, members of the World Trade Organization (WTO) signed a ministerial agreement to ensure that intellectual property rules would no longer obstruct developing countries’ efforts to protect public health. Since then, however, little has changed.

Patented medicines continue to be priced out of reach for the world's poorest people. Trade rules remain a major barrier to accessing affordable versions of patented medicines (generic medicines).

The prevalance of debilitating and life-threatening diseases in poor countries is growing, but medicines are simply not available. Urgent action is needed.  

Doha5_Final_paper_101106_2.pdf (258.6 kB)
Document Actions
Filed under: ,
Questions?

Students and researchers

Please contact research@oxfamamerica.org with questions and for help with any Oxfam research materials.

General inquiries

If you have a question or comment about any other Oxfam America publication, or would like to submit a letter to the Editor of OXFAMExchange Magazine, please contact editor@oxfamamerica.org.